Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced financial results for the quarter ended June 30, 2013.
For the quarter ended June 30, 2013, the Company incurred a net loss of $150,000, or $0.00 per basic and diluted share compared to a net loss of $6.5 million for the quarter ended June 30, 2012, or $0.16 per basic and diluted share.
Hey, check out all the research scientist jobs. Post your resume today!
